AMP Capital Investors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-273,347
| Closed | -$19.1M | – | 509 |
|
|
2021
Q3 | $19.1M | Sell |
273,347
-79,959
| -23% | -$5.62M | 0.11% | 220 |
|
|
2021
Q2 | $24.3M | Sell |
353,306
-23,697
| -6% | -$1.58M | 0.12% | 208 |
|
|
2021
Q1 | $24.4M | Sell |
377,003
-71,022
| -16% | -$4.58M | 0.12% | 198 |
|
|
2020
Q4 | $25.4M | Sell |
448,025
-23,763
| -5% | -$1.43M | 0.14% | 184 |
|
|
2020
Q3 | $29.3M | Sell |
471,788
-76,493
| -14% | -$5.3M | 0.17% | 134 |
|
|
2020
Q2 | $40.9M | Buy |
548,281
+41,074
| +8% | +$3.15M | 0.26% | 97 |
|
|
2020
Q1 | $38.5M | Sell |
507,207
-111,198
| -18% | -$7.68M | 0.28% | 86 |
|
|
2019
Q4 | $40.2M | Buy |
618,405
+1,203
| +0.2% | +$78.3K | 0.22% | 110 |
|
|
2019
Q3 | $38.8M | Sell |
617,202
-94,008
| -13% | -$6.15M | 0.22% | 114 |
|
|
2019
Q2 | $47.7M | Sell |
711,210
-38,134
| -5% | -$2.51M | 0.26% | 98 |
|
|
2019
Q1 | $47.7M | Buy |
749,344
+37,643
| +5% | +$2.5M | 0.27% | 93 |
|
|
2018
Q4 | $44M | Buy |
711,701
+28,303
| +4% | +$1.98M | 0.28% | 88 |
|
|
2018
Q3 | $52.3M | Buy |
683,398
+2,139
| +0.3% | +$162K | 0.28% | 81 |
|
|
2018
Q2 | $48.3M | Sell |
681,259
-23,985
| -3% | -$1.69M | 0.27% | 87 |
|
|
2018
Q1 | $52.7M | Buy |
705,244
+12,520
| +2% | +$995K | 0.3% | 72 |
|
|
2017
Q4 | $49.6M | Sell |
692,724
-127,368
| -16% | -$9.67M | 0.27% | 93 |
|
|
2017
Q3 | $66.4M | Buy |
820,092
+26,563
| +3% | +$2.03M | 0.37% | 66 |
|
|
2017
Q2 | $56.2M | Sell |
793,529
-36,644
| -4% | -$2.44M | 0.33% | 81 |
|
|
2017
Q1 | $56.1M | Buy |
830,173
+10,846
| +1% | +$763K | 0.33% | 76 |
|
|
2016
Q4 | $59.1M | Sell |
819,327
-11,365
| -1% | -$845K | 0.36% | 74 |
|
|
2016
Q3 | $64.7M | Buy |
830,692
+43,819
| +6% | +$3.56M | 0.4% | 64 |
|
|
2016
Q2 | $64.7M | Sell |
786,873
-61,336
| -7% | -$5.44M | 0.43% | 58 |
|
|
2016
Q1 | $78M | Buy |
848,209
+10,281
| +1% | +$927K | 0.52% | 46 |
|
|
2015
Q4 | $85.6M | Sell |
837,928
-18,504
| -2% | -$1.93M | 0.59% | 36 |
|
|
2015
Q3 | $82.2M | Buy |
856,432
+10,219
| +1% | +$1.13M | 0.6% | 31 |
|
|
2015
Q2 | $97.7M | Sell |
846,213
-110,894
| -12% | -$12.1M | 0.63% | 31 |
|
|
2015
Q1 | $96.4M | Sell |
957,107
-144,331
| -13% | -$14.7M | 0.58% | 37 |
|
|
2014
Q4 | $105M | Buy |
1,101,438
+157,747
| +17% | +$16.3M | 0.64% | 27 |
|
|
2014
Q3 | $101M | Buy |
943,691
+72,370
| +8% | +$7.09M | 0.64% | 21 |
|
|
2014
Q2 | $72.3M | Buy |
871,321
+12,560
| +1% | +$978K | 0.45% | 50 |
|
|
2014
Q1 | $58.9M | Buy |
858,761
+144,975
| +20% | +$11.4M | 0.4% | 58 |
|
|
2013
Q4 | $53.6M | Buy |
713,786
+154,482
| +28% | +$10.8M | 0.38% | 63 |
|
|
2013
Q3 | $35.5M | Buy |
559,304
+70,903
| +15% | +$4.24M | 0.27% | 85 |
|
|
2013
Q2 | $24.9M | Buy |
+488,401
| New | +$25.5M | 0.19% | 117 |
|
Other funds holding GILD
AMP Capital Investors's GILD Position: Q4 2021 in Review
AMP Capital Investors sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 273,347 shares — an estimated $19.1M sold.
AMP Capital Investors first reported a position in GILD in Q2 2013 and held it in 34 quarters. The position peaked at $105M in Q4 2014. 1,683 funds tracked by Wall St. Rank hold GILD as of Q4 2021.
- AMP Capital Investors reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
- AMP Capital Investors sold 273,347 Gilead Sciences shares in Q4 2021, an estimated $19.1M.
- AMP Capital Investors first reported a position in Gilead Sciences in Q2 2013 and held it in 34 quarters.
- AMP Capital Investors's Gilead Sciences position peaked at $105M in Q4 2014.
- 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.
Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.